DENTSPLY SIRONA (NASDAQ:XRAY) Shares Gap Down – Should You Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $13.08, but opened at $12.79. DENTSPLY SIRONA shares last traded at $12.89, with a volume of 176,378 shares traded.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Barrington Research decreased their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price on the stock. in a report on Tuesday. Thirteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $22.58.

DENTSPLY SIRONA Price Performance

The company’s 50-day simple moving average is $15.83 and its 200 day simple moving average is $18.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of -6.11, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 5.06%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in XRAY. Nordea Investment Management AB raised its stake in shares of DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after buying an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the period. Bank of New York Mellon Corp boosted its stake in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after buying an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after acquiring an additional 35,360 shares during the period. Finally, Barclays PLC raised its stake in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after acquiring an additional 54,920 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.